Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CPT-11. The European experience.
Armand JP, Terret C, Couteau C, Rixe O. Armand JP, et al. Among authors: terret c. Ann N Y Acad Sci. 1996 Dec 13;803:282-91. doi: 10.1111/j.1749-6632.1996.tb26398.x. Ann N Y Acad Sci. 1996. PMID: 8993522 Review.
CPT-11: the European clinical development.
Terret C, Couteau C, Armand JP. Terret C, et al. J Infus Chemother. 1996 Summer;6(3):152-7. J Infus Chemother. 1996. PMID: 9229329 Review.
Safety, tolerability and antitumour activity of LY2780301 (p70S6K/AKT inhibitor) in combination with gemcitabine in molecularly selected patients with advanced or metastatic cancer: a phase IB dose escalation study.
Angevin E, Cassier PA, Italiano A, Gonçalves A, Gazzah A, Terret C, Toulmonde M, Gravis G, Varga A, Parlavecchio C, Paci A, Poinsignon V, Soria JC, Drubay D, Hollebecque A. Angevin E, et al. Among authors: terret c. Eur J Cancer. 2017 Sep;83:194-202. doi: 10.1016/j.ejca.2017.06.036. Epub 2017 Jul 24. Eur J Cancer. 2017. PMID: 28750271 Clinical Trial.
Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumours. A study by the EORTC Early Clinical Study Group (ECSG).
Terret C, Zanetta S, Roché H, Schellens JH, Faber MN, Wanders J, Ravic M, Droz JP; EORTC Early Clinical Study Group. Terret C, et al. Eur J Cancer. 2003 May;39(8):1097-104. doi: 10.1016/s0959-8049(03)00128-x. Eur J Cancer. 2003. PMID: 12736109 Clinical Trial.
67 results